Peroxisome proliferator-activated receptor agonists, hyperlipidaemia, and atherosclerosis.
about
Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR)Association of common variation in the PPARA gene with incident myocardial infarction in individuals with type 2 diabetes: a Go-DARTS studyPomegranate flower: a unique traditional antidiabetic medicine with dual PPAR-alpha/-gamma activator propertiesKey issues in the role of peroxisome proliferator-activated receptor agonism and cell signaling in trichloroethylene toxicity.PPAR-alpha effects on the heart and other vascular tissues.Macrophage cholesterol transport: a critical player in foam cell formation.Novel peroxisome proliferator-activated receptor ligands for Type 2 diabetes and the metabolic syndrome.Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome.PPAR Action in Human Placental Development and Pregnancy and Its Complications.Orphan nuclear receptors: therapeutic opportunities in skeletal muscle.Animal models of catheter-induced intimal hyperplasia in type 1 and type 2 diabetes and the effects of pharmacologic intervention.Iatrogenic severe depression of high-density lipoprotein cholesterol.Peroxisome proliferator-activated receptors and atherosclerosis.PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ.PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α.Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids.Prospective study of bezafibrate for the treatment of primary sclerosing cholangitis.Hyperglycemia induces the variations of 11β-hydroxysteroid dehydrogenase type 1 and peroxisome proliferator-activated receptor-γ expression in hippocampus and hypothalamus of diabetic rats.Differential effects of peroxisome proliferator activator receptor-alpha and gamma ligands on intimal hyperplasia after balloon catheter-induced vascular injury in Zucker rats.Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes.Exploration and analysis of drug modes of action through feature integration.Ameliorative role of gemfibrozil against partial abdominal aortic constriction-induced cardiac hypertrophy in rats.Enantioselective Synthesis of a Novel Thiazoline Core as a Potent Peroxisome Proliferator-Activated Receptor δ Agonist.PPARα: essential component to prevent myocardial oxidative stress?
P2860
Q24793496-03C1E43B-49B7-4DDF-83A2-F0B44E7D1823Q24813954-B458391F-05A3-42C2-AA80-757BC2832469Q28261771-DE9393CB-455B-42E4-9597-5DA04727BB28Q35039302-3D08DFDC-9334-4A62-B977-05A99F1FABD7Q35080447-56EE4103-5E94-4EE3-8D1B-EF12A4564FDDQ35160967-D4E68BE5-504E-45E9-BDE4-BCC5C52DFF07Q35207615-05C9E9C9-AB03-4302-9BE9-908AFB04AB59Q36018562-C5645396-784B-4F12-B393-5636E45A9541Q36446678-13A140AD-5D17-421C-9DA4-BB23BB94820BQ36529528-03444F16-1A8D-4913-A288-69B84A74F6E2Q37367896-B057571C-EB27-4DCE-85A7-B609EE215530Q37464513-9B811EC4-56B0-44FD-ACBB-3E9C096DDF7EQ37861955-99B29FAB-A792-4665-BDAD-6112228C8502Q38674739-C309CBBF-9187-4224-AFF1-2DB4913E70EDQ38674742-36F38442-2519-4F57-A48C-A72C3298FAF1Q40425308-4EAED97E-D3E1-4FC1-8A05-6E935463D84FQ40738996-BAF4D48C-E59E-4AEE-9548-FD9E04FFDCB2Q42225428-8EBADED3-F5EA-48B2-9304-6A5A19E447B3Q44739755-364BAE4A-C5B0-4F37-AD97-A6D53EB59468Q44990830-2168D870-35E1-41D7-B7CD-A75EF4012873Q48009618-989A3F14-FD3C-4855-A004-18A5BA2A1E4EQ50469548-FFF62C46-0A17-400F-913F-4E7AC454C397Q55655009-14299D7A-B46A-4D93-99D7-5460AE56FF55Q59200913-FEE67600-51F6-49C6-B17C-ADD74FA7064A
P2860
Peroxisome proliferator-activated receptor agonists, hyperlipidaemia, and atherosclerosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Peroxisome proliferator-activa ...... pidaemia, and atherosclerosis.
@ast
Peroxisome proliferator-activa ...... pidaemia, and atherosclerosis.
@en
Peroxisome proliferator-activa ...... pidaemia, and atherosclerosis.
@nl
type
label
Peroxisome proliferator-activa ...... pidaemia, and atherosclerosis.
@ast
Peroxisome proliferator-activa ...... pidaemia, and atherosclerosis.
@en
Peroxisome proliferator-activa ...... pidaemia, and atherosclerosis.
@nl
prefLabel
Peroxisome proliferator-activa ...... pidaemia, and atherosclerosis.
@ast
Peroxisome proliferator-activa ...... pidaemia, and atherosclerosis.
@en
Peroxisome proliferator-activa ...... pidaemia, and atherosclerosis.
@nl
P1476
Peroxisome proliferator-activated receptor agonists, hyperlipidaemia, and atherosclerosis
@en
P2093
Guennadi A Khoudoli
Tracey L Graham
P356
10.1016/S0163-7258(02)00232-2
P577
2002-07-01T00:00:00Z